medigraphic.com
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

2015, Number 3

<< Back Next >>

Rev Esp Med Quir 2015; 20 (3)

Clinical and epidemiological profiles of patients with diabetic foot

Torres-Valenzuela A, Rodríguez-Gil A, Valles-Araiza DA, Vásquez-García R, Lerma-Burciaga CG

Language: Spanish
References: 34
Page: 294-301
PDF size: 442.74 Kb.


ABSTRACT

The diabetic foot is a complication of diabetes, which induces a neuropathy and/or peripheral vascular injury that causes tissue damage, which may need amputations.
Objective: Learn about clinical and epidemiological profiles of patients with diabetic foot to improve protocols and provide quality care.
Materials and methods: It was a descriptive study based on the clinical records of patients seen over a year in the General Hospital Dr. Santiago Ramon y Cajal, ISSSTE in Durango City, Mexico.
Results: 50 patients, corresponding to 26.6% of patients with diabetes, their average age was 64.5 years, 60% male, 66% retirees and pensioners were studied; 94% had type 2 diabetes with a mean of 16.3 years of evolution. The most frequently comorbidities was hypertension (82%) and nephropathy 26%. 34% had a previous amputation. At their entry to hospital, 96% had skin lesion, ulcer 56% and 62% had infection. The toes showed most of the injuries, followed by the foot. During their last stay 36 (72%) patients underwent amputation: 25 of them in toes, 3 in foot, 7 at supracondylar region and 1 at infracondylar region.
Conclusions: The clinical and epidemiological profile, described highlights the need to strengthen the programs of prevention and health promotion, early detection, adherence to treatment and re- enforce self-care in diabetic patients and in populations with risk factors.


REFERENCES

  1. American Diabetes Association. Complicaciones de los pies. Marzo 2015. Disponible en: http://www.diabetes.org/es/ vivir-con-diabetes/complicaciones/complicaciones-en-lospies. html#sthash.JkTNsAk8.dpuf

  2. Hurley L, Kelly L, Garrow AP, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for foot ulceration: the West of Ireland Diabetes Foot Study QJM 2013;12:1103–1110.

  3. Reiber G, Vileikyte L, Boyko E. Causal pathways for incident lower extremity ulcers in patients with diabetes from two settings.Diabetes Care1999;22:157-162.

  4. Lavery L, Higgins K, Lanctot D. Preventing Diabetic Foot Ulcer Recurrence in High-Risk Patients. Diabetes Care 2007;1:14–20.

  5. Holzer S, Camerota A, Martens L. Costs and duration of care for Lower extremity ulcers in patients with diabetes. Clin Ther 1998;20:169–181.

  6. Metha SS, Suzuki S, Glick HA, Schulman KA. Determining an episode of care using claims data: diabetic foot ulcer. Diabetes Care 1999;22(7):1110-1115.

  7. Levin ME. Preventing amputation in the patient with diabetes. Diabetes Care 1995;18(10):1383-1394.

  8. Ollendorf, DA, Kotsanos J, James G, Wishner WJ, Fried- man M, Cooper, T, Bittoni, M, Oster G. Potential economic benefits of lower-extremity amputation prevention strategies in diabetes. Diabetes Care 1998;21(8):1240-1245.

  9. Reiber GE, Bokyo EJ, Smith DG. Lower extremity foot ulcers and amputations in diabetes. In Harris M.I., Cowie C.C., Stem, M.P., et al (eds): Diabetes in America, ed. (DHHS Publication No. 95-1468). Washington, DC, US Government Printing Office, 1995, pp. 409-428.

  10. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nat Rev Endocrinol. 2011;8(4):228-36.

  11. Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernández S, Franco A, Cuevas-Nasu L, Romero-Martínez M, Hernández-Ávila M. Encuesta 12. Irkovska A. Care of patients with the diabetic foot syndrome based on an international consensus. Cas Lek Cesk 2001;140(8):230-3.

  12. Nacional de Salud y Nutrición 2012. Resultados Nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública (MX), 2012.

  13. Meijer JW, Trip J, Jaegers SM, Links TP, Smith Aj, Groothoff JW et al. Qualify of life in patiens with diabetic foot ulcers. Disabil Rehabil 2001;23(8):336-40.

  14. Santos D, Carline T. Examination of the lower limb in high risk patients. J Tissue Viab 2000;10(3):97-105.

  15. Got I. Necessary multidisciplinary management of diabetic foot. J Mal Vasc 2001;26(2):130-4.

  16. Mc Cook MJ. Montalvo DJ. Ariosa CM, Fernández HP. Hacia una clasificación etiopatogénica del llamado pie diabético. Angiología 1979;31:9-11.

  17. Arboleya Casanova Heberto, Morales Andrade Eduardo. Epidemiología del pie diabético:Base de datos de la CONAMED. Rev CONAMED 2008;13(1):15-23.

  18. Camacho Ortiz Jessyca Ivonne, Conrado Aguilar Sofía, Rosas Barrientos José Vicente.Manejo del pie diabético en Medicina Interna de 2011 a 2012, Hospital Regional 1º de Octubre. Rev Esp Med Quir 2014;19(3):284-293.

  19. Reynaga Aguilar Luz Elena, Ramos Hernández Gabino, Torres Benítez José Martín. Diferencias de género y grupo etáreo en pacientes con pie diabético. Rev Esc Med Dr J Sierra 2014;28(1):4-11.

  20. Lin PJ1, Kent DM, Winn A, Cohen JT, Neumann PJ. Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequences. Am J Manag Care 2015;21(1):e23-34.

  21. Klimek P, Kautzky-Willer A, Chmiel A, Schiller-Frühwirth I, Thurner S. Quantification of Diabetes Comorbidity Risks across Life Using Nation-Wide Big Claims Data. PLoS Comput Biol 2015;11(4).

  22. Tecilazich F, Dinh T, Veves A. Treating diabetic ulcers. Expert Opin Pharmacother 2011;12(4):593-606.

  23. Aumiller WD, Dollahite HA. Pathogenesis and management of diabetic foot ulcers. JAAPA. 2015;28(5):28-34.

  24. Andrews KL, Houdek MT, Kiemele LJ. Wound management of chronic diabetic foot ulcers: from the basics to regenerative medicine. Prosthet Orthot Int 2015;39(1):29-39.

  25. Morbach S, Müller E, Reike H, Risse A, Rümenapf G, Spraul M; German Diabetes Association. Diabetic foot syndrome. Exp Clin Endocrinol Diabetes 2014;122(7):416-24.

  26. Chantelau EA. Nociception at the diabetic foot, an uncharted territory. World J Diabetes 2015;6(3):391-402.

  27. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet 2005;366(9498);1719-24.

  28. Y. C. Lu, Q. C. Mei, Y. D. Gu. Plantar Loading Reflects Ulceration Risks of Diabetic Foot with Toe Deformation. Biomed Res Int ;2015:326-493.

  29. Lipsky BA, Berendt A, Deery HG, et al. for the Infectious Diseases Society of America. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004;39(7):885–910.

  30. Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med 1997;14(1):29–34.

  31. Charles PG, Uçkay I, Kressmann B, Emonet S, Lipsky BA.The role of anaerobes in diabetic foot infections. Anaerobe 2015;34:8-13.

  32. Padrón Arredondo Guillermo. Amputaciones en un hospital general en pacientes con pié diabético.Análisis de tres años. Rev Sal Quintana Roo 2013;6(25):26-31.

  33. Søndergaard LN, Christensen AB, Vinding AL, Kjær IL, Larsen P. Elevated costs and high one-year mortality in patients with diabetic foot ulcers after surgery. Dan Med J 2015;62(4).

  34. García García Yudit, Del Olmo Pimentel Dunit, Zoe Valor Iris, Barnés Domínguez José A, Valdés Pérez Calixto. Caracterización clínica de pacientes hospitalizados con una primera amputación de miembros inferiores por pie diabético. Rev Cubana Angiol y Cir Vasc 2013;13(2).




2020     |     www.medigraphic.com